Perflubron
Generic Name: perflubron
Manufactured by ALLIANCE PHARM. Dosage form: LIQUID. Route: ORAL. Active ingredients: PERFLUBRON (100%). Application: NDA020091.
Overview
Manufactured by ALLIANCE PHARM. Dosage form: LIQUID. Route: ORAL. Active ingredients: PERFLUBRON (100%). Application: NDA020091.
Dosage
Available as liquid for oral use.
Related Medications
Lexiscan(r) (regadenoson)
lexiscan(r) (regadenoson)
Adenosine Receptor Agonist [EPC]
11 DESCRIPTION Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator [see Clinical Pharmacology ( 12- 12.1)]. Regadenoson is chemically described as adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-, monohydrate. Its structural formula is: The molecular formula for regadenoson is C15H18N8O5 • H2O and its molecular weight is 408.37. LEXISCAN is a sterile, nonpyrogenic solution for intravenous injection. The solution is clear and colorless.
Guaifenesin And Pseudoephedrine Hcl
guaifenesin and pseudoephedrine hcl
Expectorant [EPC]
Purpose Expectorant and Nasal Decongestant
Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136/rv/2023 (h3n2) Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated)
influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136/rv/2023 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated)
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (60 ug/.5mL); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (60 ug/.5mL); INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) (60 ug/.5mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.